OTSUKA HOLDINGS CO. LTD.

Company Snapshot

Founded: 2008
Entity Type: Public
Employees: 34388
Region: Japan
Revenue: $14,400.5 Millions
Revenue Year: 2023
Headquarter: Tokyo, japan
Key Geographics: Japan, North America, Europe and Others
Corporate Address: 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan Tel. +81-3-6717-1410 www.otsuka.com

Company Overview

Otsuka Holdings Co. Ltd. is a Japanese multinational conglomerate headquartered in Tokyo. It operates in several industries, including pharmaceuticals, nutraceuticals and consumer products. Otsuka Holdings it owns and manages a portfolio of 74 subsidiaries that operate in various industries worldwide. The company is organized into four business segments: pharmaceuticals, nutraceuticals, consumer products and other businesses. Otsuka Pharmaceutical Co. Ltd. is the largest subsidiary, accounting for most of the company’s revenue.

Otsuka also has a significant presence in the nutraceuticals industry through its subsidiary Otsuka Pharmaceutical Factory Inc., which produces nutritional supplements, health foods and other products. According to the company’s 2022 annual report, Otsuka’s functional food and drinks revenue increased as consumers re-evaluated the value of “Nutritionally Balanced Food” amid the growing interest in health and dietary habits worldwide.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

OTSUKA HOLDINGS CO. LTD. In Reports

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

BCC Research Report: Dive into pharmaceutical drugs market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Neurology Market: A BCC Research Overview

BCC Research Report: Dive into neurology market Key products are analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2029.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

BCC Research Market Analyst says global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029

Company's Business Segments

  • Pharmaceuticals : ABILIFY MAINTENA, REXULTI, Samsca/JINARC/JYNARQUE, LONSURF.
  • Nutraceuticals : POCARI SWEAT, Nature Made, Nutrition and Sante, Daiya, EQUELLE, BODYMAINTE.
  • Consumer products : Bon Curry, MY SIZE retort pouch, Mannan Hikari, ZERO MEAT.
  • Others : Otsuka Chemical, Otsuka Warehouse.

Applications/End User Industries

  • Pharmaceuticals
  • Healthcare
  • Nutraceuticals